Delivery Order SPE2DB24D2205-SPE2DB24FDXSP
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $4,700.16 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,681,900 units of the prescription drug Tivicay 50 mg Tablet 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,002.93 firm fixed-price delivery order is for the supply of Tivicay 50 mg tablets, a medication used to treat HIV infection. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,882.29 contract is for the supply of 4,567,943,511 units of the pharmaceutical product Tivicay 50 mg Tablet 30s. The contract has an ultimate completion date of April 17, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,671.25, is for the delivery of 4,567,984,596 units of the prescription medication Tivicay 50 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $27,736.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Tivicay 50 mg tablets, a medication used to treat human immunodeficiency virus (HIV) infection. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tivicay 50 mg tablets, a medication used to treat HIV infection. The contract has a ceiling value of $2,820.56 and runs through March 10, 2025. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $47,433.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Tivicay 50 mg tablets, a medication used to treat HIV/AIDS. The contract has an ultimate completion date of July 24, 2024 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $17,083.88 firm-fixed-price contract is for the supply of 4,565,307,744 units of the pharmaceutical product TIVICAY 50 MG TABLET 30S. The contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $17,051.31 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply TIVICAY 50 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,688.55 firm fixed-price delivery order is for the supply of Tivicay 50 mg tablets, a medication used to treat human immunodeficiency virus (HIV) infection. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...